UnitedHealth Group SG&A increased by 10.5% to $15.22B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $13.28B to $15.22B. Over 3 years (FY 2021 to FY 2024), SG&A shows an upward trend with a 7.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
is_selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.36B | $10.73B | $11.27B | $11.40B | $11.71B | $11.66B | $13.01B | $13.63B | $13.81B | $13.86B | $13.34B | $14.08B | $13.16B | $13.28B | $12.49B | $13.59B | $13.78B | $15.22B |
| QoQ Change | — | +3.5% | +5.1% | +1.1% | +2.7% | -0.4% | +11.5% | +4.7% | +1.4% | +0.3% | -3.7% | +5.5% | -6.5% | +0.9% | -5.9% | +8.8% | +1.4% | +10.5% |
| YoY Change | — | — | — | — | +13.0% | +8.7% | +15.4% | +19.5% | +17.9% | +18.8% | +2.5% | +3.3% | -4.7% | -4.2% | -6.3% | -3.4% | +4.7% | +14.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.